Le Métier will use Glycinamide in its premium range of ‘Peau Vierge’ anti-ageing creams that will be commercialised
initially across the USA through department stores such as Neiman Marcus, Bergdorf Goodman and Nordstrom.
Le Métier is responsible for all future costs including formulation, manufacturing and marketing. Under the terms of
the agreement Phylogica will receive a significant royalty on all sales of Le Métier’s cosmetic products that contain
Glycinamide.
Le Métier is making excellent progress towards a first launch in late 2013/early 2014. The formulation work is ongoing.
It has identified a class of cosmetically acceptable solvents for the peptide and are currently combining the Glycinamide
formulation with an effective skin penetration enhancer.
This could be worth something!! Page 5 of annual report.
- Forums
- ASX - By Stock
- PYC
- potential revenue in 2014
PYC
pyc therapeutics limited
Add to My Watchlist
3.03%
!
$1.28

potential revenue in 2014
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M |
Open | High | Low | Value | Volume |
$1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | $1.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 40248 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 1.275 |
1 | 13987 | 1.265 |
2 | 16060 | 1.260 |
1 | 12000 | 1.255 |
2 | 2800 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 40248 | 3 |
1.330 | 5000 | 1 |
1.345 | 53113 | 2 |
1.350 | 22000 | 2 |
1.360 | 5958 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online